What have we learned about optimal induction therapy for lupus nephritis (III through V) from randomized, controlled trials?

Clin J Am Soc Nephrol. 2008 May;3(3):895-8. doi: 10.2215/CJN.00170108. Epub 2008 Feb 20.
No abstract available

MeSH terms

  • Drug Therapy, Combination
  • Evidence-Based Medicine
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Lupus Nephritis / drug therapy*
  • Lupus Nephritis / mortality
  • Lupus Nephritis / pathology
  • Practice Guidelines as Topic
  • Randomized Controlled Trials as Topic*
  • Research Design*
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Immunosuppressive Agents